Eldecalcitol is a drug used in Japan for the treatment of osteoporosis. It is an analog of vitamin D. Eldecalcitol is an orally administered drug to patients, which binds to vitamin D receptors and binding protein for the goal of achieving greater specificity to bind calcium for its absorption. This greater affinity is 2.7-fold that of the active vitamin D form of calcitriol. Eldecalcitol is readily absorbed into the body, with a long elimination half-life of over eight hours, reaching maximum absorption in 3.4 hours.
Properties:
Density: 1.1g/cm3
Melting Point: 126-128ºC
Boiling Point: 655.7ºC at 760mmHg
Flash Point: 350.3ºC
Refractive Index: 1.55
Vapor Pressure: 5.68E-20mmHg at 25°C
Related Prodcuts:
Eldecalcitol Intermediates CD; Eldecalcitol Intermediates A; Eldecalcitol intermediates(66774-84-3; 200636-42-6)